95 related articles for article (PubMed ID: 9031467)
1. Isolation and regulation of the cGMP-inhibited cAMP phosphodiesterase in human erythroleukemia cells.
Sheth SB; Brennan KJ; Biradavolu R; Colman RW
Thromb Haemost; 1997 Jan; 77(1):155-62. PubMed ID: 9031467
[TBL] [Abstract][Full Text] [Related]
2. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Maurice DH
Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
Liu H; Maurice DH
Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of gamma-globin gene expression by cyclic AMP-dependent pathway in erythroid cells.
Inoue A; Kuroyanagi Y; Terui K; Moi P; Ikuta T
Exp Hematol; 2004 Mar; 32(3):244-53. PubMed ID: 15003309
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases.
Michie AM; Rena G; Harnett MM; Houslay MD
Cell Biochem Biophys; 1998; 28(2-3):161-85. PubMed ID: 9515165
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
Manns JM; Brenna KJ; Colman RW; Sheth SB
Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
[TBL] [Abstract][Full Text] [Related]
9. Platelet cyclic adenosine monophosphate phosphodiesterases: targets for regulating platelet-related thrombosis.
Colman RW
Semin Thromb Hemost; 2004 Aug; 30(4):451-60. PubMed ID: 15354266
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cyclic 3',5'-adenosine monophosphate phosphodiesterase in Friend erythroleukemia cells.
Mason M; Narindrasorasak S; Sanwal BD
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(2):129-42. PubMed ID: 2582013
[TBL] [Abstract][Full Text] [Related]
11. Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.
Zhang W; Ke H; Tretiakova AP; Jameson B; Colman RW
Protein Sci; 2001 Aug; 10(8):1481-9. PubMed ID: 11468344
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3.
Surapisitchat J; Jeon KI; Yan C; Beavo JA
Circ Res; 2007 Oct; 101(8):811-8. PubMed ID: 17704206
[TBL] [Abstract][Full Text] [Related]
13. A new nonhydrolyzable reactive cAMP analog, (Sp)-adenosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase.
Hung SH; Madhusoodanan KS; Beres JA; Boyd RL; Baldwin JL; Zhang W; Colman RW; Colman RF
Bioorg Chem; 2002 Feb; 30(1):16-31. PubMed ID: 11955000
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
[TBL] [Abstract][Full Text] [Related]
15. 3'5'-cyclic adenosine monophosphate-dependent up-regulation of phosphodiesterase type 3A in porcine cumulus cells.
Sasseville M; Côté N; Vigneault C; Guillemette C; Richard FJ
Endocrinology; 2007 Apr; 148(4):1858-67. PubMed ID: 17218408
[TBL] [Abstract][Full Text] [Related]
16. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
17. Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line.
Delgado M; Fernández-Alfonso MS; Fuentes A
Arch Dermatol Res; 2002 Jul; 294(4):190-7. PubMed ID: 12111350
[TBL] [Abstract][Full Text] [Related]
18. New insight into the role of phosphodiesterase 3A in porcine oocyte maturation.
Sasseville M; Côté N; Guillemette C; Richard FJ
BMC Dev Biol; 2006 Oct; 6():47. PubMed ID: 17038172
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells.
Yao J; Hiramatsu N; Zhu Y; Morioka T; Takeda M; Oite T; Kitamura M
J Am Soc Nephrol; 2005 Jan; 16(1):58-67. PubMed ID: 15537869
[TBL] [Abstract][Full Text] [Related]
20. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]